STAT+: Lack of access to antibiotics for drug-resistant infections often blamed on poor care, study says
\n \t
\n
<\/BR>
\n
\n \t
\n
<\/BR><\/p>\n
Only 6.9% of people with drug-resistant infections in eight large, low- and middle-income countries received an appropriate antibiotic in 2019 and the lack of access was largely attributed to insufficient care, according to a new analysis.<\/p>\n
The researchers examined several antibiotics that were suitable to treat nearly 1.5 million cases of carbapenem-resistant gram-negative infections, which are highly resistant to drugs, in geographically diverse countries \u2014 Bangladesh, Brazil, Egypt, India, Kenya, Mexico, Pakistan, and South Africa. But availability was low in each country, ranging from 0.2% to 14.9%.<\/p>\n
The findings, which were published in The Lancet<\/a>, underscored potentially significant gaps in care that may otherwise have made it possible to access the available antibiotics, according to Jennifer Cohn, a senior author of the study and the global access director at the Global Antibiotic Research & Development Partnership, a nonprofit health organization.<\/p>\n Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n